Unravelling similarities and differences in the role of circular and linear PVT1 in cancer and human disease

• Published in: British journal of cancer 2022-04, Vol.126 (6), p.835-850
• Main Authors: Traversa, Debora, Simonetti, Giorgia, Tolomeo, Doron, Visci, Grazia, Macchia, Gemma, Ghetti, Martina, Martinelli, Giovanni, Kristensen, Lasse S., Storlazzi, Clelia Tiziana
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; 631/67/1857; 631/67/68; AKT protein; Animals; Apoptosis; Biomedical and Life Sciences; Biomedicine; Cancer Research; Carcinogenesis; Cell Line, Tumor; Cell proliferation; Cell Proliferation - genetics; Disease; Drug metabolism; Drug Resistance; Epidemiology; Gene expression; Genomes; Genomics; Humans; MicroRNAs; MicroRNAs - genetics; Molecular Medicine; Myc protein; Neoplasms - genetics; Neoplasms - pathology; Oncology; Phosphatidylinositol 3-Kinases; Plasmacytoma; Prognosis; Prostate cancer; Proteins; Review; Review Article; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism; Roles; Stat3 protein; Transcription; Tumors; Vimentin
• ISSN: 0007-0920; 1532-1827; 1532-1827
• DOI: 10.1038/s41416-021-01584-7

The plasmacytoma variant translocation 1 ( PVT1 ) is a long non-coding RNA gene involved in human disease, mainly in cancer onset/progression. Although widely analysed, its biological roles need to be further clarified. Notably, functional studies on PVT1 are complicated by the occurrence of multiple transcript variants, linear and circular, which generate technical issues in the experimental procedures used to evaluate its impact on human disease. Among the many PVT1 transcripts, the linear PVT1 (lncPVT1) and the circular hsa_circ_0001821 (circPVT1) are frequently reported to perform similar pathologic and pro-tumorigenic functions when overexpressed. The stimulation of cell proliferation, invasion and drug resistance, cell metabolism regulation, and apoptosis inhibition is controlled through multiple targets, including MYC, p21, STAT3, vimentin, cadherins, the PI3K/AKT, HK2, BCL2, and CASP3. However, some of this evidence may originate from an incorrect evaluation of these transcripts as two separate molecules, as they share the lncPVT1 exon-2 sequence. We here summarise lncPVT1/circPVT1 functions by mainly focusing on shared pathways, pointing out the potential bias that may exist when the biological role of each transcript is analysed. These considerations may improve the knowledge about lncPVT1/circPVT1 and their specific targets, which deserve further studies due to their diagnostic, prognostic, and therapeutic potential.